1-Hydroxybenzotriazole → HCID 178516353, compound
Reaction equation
[CH:1]12[NH:8][CH:5]([CH2:6][CH2:7]1)[CH2:4][CH:3]([C:9]1[C:14]3[C:15](=[O:19])[CH2:16][CH2:17][NH:18][C:13]=3[N:12]3[N:20]=[CH:21][C:22]([C:23]4[CH:24]=[N:25][C:26]([C:29]5[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=5)=[CH:27][CH:28]=4)=[C:11]3[N:10]=1)[CH2:2]2.[NH:35]1[CH:39]=[N:38][C:37]([C:40](O)=[O:41])=[N:36]1.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C>CN(C=O)C.C(Cl)CCl>[N:35]1[N:36]=[C:37]([C:40]([N:8]2[CH:1]3[CH2:7][CH2:6][CH:5]2[CH2:4][CH:3]([C:9]2[C:14]4[C:15](=[O:19])[CH2:16][CH2:17][NH:18][C:13]=4[N:12]4[N:20]=[CH:21][C:22]([C:23]5[CH:24]=[N:25][C:26]([C:29]6[CH:30]=[CH:31][CH:32]=[CH:33][CH:34]=6)=[CH:27][CH:28]=5)=[C:11]4[N:10]=2)[CH2:2]3)=[O:41])[NH:38][CH:39]=1Participants
7
Procedure
A mixture of 5-(8-azabicyclo[3.2.1]octan-3-yl)-3-(6-phenylpyridin-3-yl)-8,9-dihydropyrazolo[1,5-a]pyrido[3,2-e]pyrimidin-6(7H)-one (86 mg, 0.19 mmoL), 1H-1,2,4-triazole-3-carboxylic acid (25.9 mg, 0.23 mmoL), EDC (73 mg, 0.38 mmoL), HOBt (51.6 mg, 0.38 mmoL) and DIEA (199 uL, 1.15 mmoL) in DMF (4 mL) was stirred at room temperature for 2 h. Purification with prep-LC provided 5-(8-(4H-1,2,4-triazole-3-carbonyl)-8-azabicyclo[3.2.1]octan-3-yl)-3-(6-phenylpyridin-3-yl)-8,9-dihydropyrazolo[1,5-a]pyrido[3,2-e]pyrimidin-6(7H)-one: LCMS tR=2.33 Min (10 min run, UV254nm). Mass calculated for, M+ 545.2, observed LC/MS m/z 546.01 (M+H).
Workup
- customPurification
Sources & evidence
- ORD record
- ord-e2dcd194197544b7b914b80009475c70
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08703784B2
Reaction notes
Loading…